- Home
- OPAL vs ADAG Comparison
OPAL vs ADAG Comparison
Compare OPAL & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAL
- ADAG
- Stock Information
- Founded
- OPAL 1998
- ADAG 2011
- Country
- OPAL United States
- ADAG China
- Employees
- OPAL N/A
- ADAG N/A
- Industry
- OPAL Natural Gas Distribution
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- OPAL Utilities
- ADAG Health Care
- Exchange
- OPAL Nasdaq
- ADAG Nasdaq
- Market Cap
- OPAL 90.7M
- ADAG 91.4M
- IPO Year
- OPAL N/A
- ADAG 2021
- Fundamental
- Price
- OPAL $2.54
- ADAG $1.95
- Analyst Decision
- OPAL Hold
- ADAG Strong Buy
- Analyst Count
- OPAL 3
- ADAG 1
- Target Price
- OPAL $3.00
- ADAG $8.00
- AVG Volume (30 Days)
- OPAL 301.9K
- ADAG 87.7K
- Earning Date
- OPAL 08-06-2025
- ADAG 07-24-2025
- Dividend Yield
- OPAL N/A
- ADAG N/A
- EPS Growth
- OPAL N/A
- ADAG N/A
- EPS
- OPAL 0.02
- ADAG N/A
- Revenue
- OPAL $320,427,000.00
- ADAG $103,204.00
- Revenue This Year
- OPAL $22.40
- ADAG $6,488.89
- Revenue Next Year
- OPAL $19.75
- ADAG $57.50
- P/E Ratio
- OPAL $134.78
- ADAG N/A
- Revenue Growth
- OPAL 15.22
- ADAG N/A
- 52 Week Low
- OPAL $1.26
- ADAG $1.33
- 52 Week High
- OPAL $4.45
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- OPAL 41.93
- ADAG 53.92
- Support Level
- OPAL $2.32
- ADAG $1.74
- Resistance Level
- OPAL $2.71
- ADAG $1.99
- Average True Range (ATR)
- OPAL 0.20
- ADAG 0.11
- MACD
- OPAL -0.07
- ADAG -0.01
- Stochastic Oscillator
- OPAL 20.37
- ADAG 58.33
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.